|
ERGIC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.187970E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.462400E-02 |
| Normal-vs-Stage2 |
3.469800E-01 |
| Normal-vs-Stage3 |
7.445200E-01 |
| Normal-vs-Stage4 |
9.588800E-01 |
| Stage1-vs-Stage2 |
5.973800E-01 |
| Stage1-vs-Stage3 |
8.635700E-02 |
| Stage1-vs-Stage4 |
1.075040E-01 |
| Stage2-vs-Stage3 |
4.887800E-01 |
| Stage2-vs-Stage4 |
4.017800E-01 |
| Stage3-vs-Stage4 |
7.541200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.273360E-01 |
| Normal-vs-AfricanAmerican |
5.418000E-01 |
| Normal-vs-Asian |
5.532600E-01 |
| Caucasian-vs-AfricanAmerican |
7.744000E-01 |
| Caucasian-vs-Asian |
6.173600E-01 |
| AfricanAmerican-vs-Asian |
9.350200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.295600E-01 |
| Normal-vs-Female |
4.952300E-02 |
| Male-vs-Female |
7.016400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.160000E-02 |
| Normal-vs-Age(41-60Yrs) |
3.218000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.284200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.827200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.136200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.128000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.438200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.724600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.097000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.732400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.324600E-01 |
| Classical-VS-Follicular |
6.566600E-01 |
| Classical-VS-Other |
1.683170E-01 |
| Classical-VS-Normal |
5.741700E-02 |
| Tall-VS-Follicular |
6.849800E-01 |
| Tall-VS-Other |
1.830010E-01 |
| Tall-VS-Normal |
1.773610E-01 |
| Follicular-VS-Other |
4.368000E-01 |
| Follicular-VS-Normal |
4.003200E-01 |
| Other-VS-Normal |
5.805200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.341800E-01 |
| Normal-vs-N1 |
8.576600E-01 |
| N0-vs-N1 |
5.987400E-01 |
|
|
